These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 11986090)

  • 21. Ocular toxoplasmosis: clinical characteristics in pediatric patients.
    Garza-Leon M; Garcia LA
    Ocul Immunol Inflamm; 2012 Apr; 20(2):130-8. PubMed ID: 22409567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ocular manifestations of congenital infection: a study of the early effect and long-term outcome of maternally transmitted rubella and toxoplasmosis.
    O'Neill JF
    Trans Am Ophthalmol Soc; 1998; 96():813-79. PubMed ID: 10360309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ocular Toxoplasmosis: an Update.
    Garweg JG
    Klin Monbl Augenheilkd; 2016 Apr; 233(4):534-9. PubMed ID: 27116531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical manifestations and visual outcomes associated with ocular toxoplasmosis in a Brazilian population.
    Arruda S; Vieira BR; Garcia DM; Araújo M; Simões M; Moreto R; Rodrigues MW; Belfort R; Smith JR; Furtado JM
    Sci Rep; 2021 Feb; 11(1):3137. PubMed ID: 33542439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactivations of ocular toxoplasmosis after cataract extraction.
    Bosch-Driessen LH; Plaisier MB; Stilma JS; Van der Lelij A; Rothova A
    Ophthalmology; 2002 Jan; 109(1):41-5. PubMed ID: 11772577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging of congenital toxoplasmosis macular scars with optical coherence tomography.
    Garg S; Mets MB; Bearelly S; Mets R
    Retina; 2009 May; 29(5):631-7. PubMed ID: 19262439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ocular toxoplasmosis: our experience].
    Russo M; Pergola G; Pedicini G
    Infez Med; 2005 Sep; 13(3):160-7. PubMed ID: 16397419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination.
    Dodds EM; Holland GN; Stanford MR; Yu F; Siu WO; Shah KH; Ten Dam-van Loon N; Muccioli C; Hovakimyan A; Barisani-Asenbauer T;
    Am J Ophthalmol; 2008 Dec; 146(6):856-65.e2. PubMed ID: 19027421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinal detachment associated with ocular toxoplasmosis.
    Faridi A; Yeh S; Suhler EB; Smith JR; Flaxel CJ
    Retina; 2015 Feb; 35(2):358-63. PubMed ID: 25127047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular Toxoplasmosis in a Tertiary Referral Center in Sydney Australia-Clinical Features, Treatment, and Prognosis.
    Yates WB; Chiong F; Zagora S; Post JJ; Wakefield D; McCluskey P
    Asia Pac J Ophthalmol (Phila); 2019; 8(4):280-284. PubMed ID: 31369405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary Ocular Toxoplasmosis Presenting to Uveitis Services in a Non-endemic Setting.
    Bhikoo R; Damato EM; Guest S; Sims J
    Korean J Ophthalmol; 2019 Dec; 33(6):514-519. PubMed ID: 31833248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular manifestations in congenital toxoplasmosis.
    Kodjikian L; Wallon M; Fleury J; Denis P; Binquet C; Peyron F; Garweg JG
    Graefes Arch Clin Exp Ophthalmol; 2006 Jan; 244(1):14-21. PubMed ID: 15906073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of drug therapy on the risk of recurrence of ocular toxoplasmosis.
    Reich M; Becker MD; Mackensen F
    Br J Ophthalmol; 2016 Feb; 100(2):195-9. PubMed ID: 26163541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Birdshot chorioretinopathy: long-term manifestations and visual prognosis.
    Rothova A; Berendschot TT; Probst K; van Kooij B; Baarsma GS
    Ophthalmology; 2004 May; 111(5):954-9. PubMed ID: 15121374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
    Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS
    Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Posterior segment manifestations of active ocular syphilis, their response to a neurosyphilis regimen of penicillin therapy, and the influence of human immunodeficiency virus status on response.
    Browning DJ
    Ophthalmology; 2000 Nov; 107(11):2015-23. PubMed ID: 11054325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visual loss in uveitis of childhood.
    de Boer J; Wulffraat N; Rothova A
    Br J Ophthalmol; 2003 Jul; 87(7):879-84. PubMed ID: 12812891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical features and prognosis in ocular toxoplasmosis.
    Atmaca LS; Simsek T; Batioglu F
    Jpn J Ophthalmol; 2004; 48(4):386-91. PubMed ID: 15295668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spectral optical coherence tomography findings in patients with ocular toxoplasmosis and active satellite lesions (MINAS Report 1).
    Oréfice JL; Costa RA; Scott IU; Calucci D; Oréfice F;
    Acta Ophthalmol; 2013 Feb; 91(1):e41-7. PubMed ID: 22970804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
    Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
    Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.